πŸ‡ΊπŸ‡Έ FDA
Patent

US 8604184

Chemically programmable immunity

granted A61KA61K31/7088A61P

Quick answer

US patent 8604184 (Chemically programmable immunity) held by United States of America as represented by the Secretary of the Air Force expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/7088, A61P, A61P31/04, A61P31/16